Waves Multirack Native Software Torrent Download
Heike Fallago
DiGiGrid is a collaboration between Waves and DiGiCo/Soundtracs that aims to provide the audio market with processing and networking solutions based on the Waves SoundGrid platform. DiGiGrid offers audio interfaces for native DAWs, Pro Tools systems, Waves MultiRack and MADI-enabled consoles.
SoundGrid is the Waves networking and processing platform for real-time professional audio applications. Audio networking occurs over standard Ethernet infrastructure. Real-time processing uses Intel DSP SoundGrid servers.
Software: The SoundGrid Studio Application and a SoundGrid ASIO/Core Audio driver. Additional SoundGrid software (MultiRack SoundGrid, StudioRack SoundGrid, the eMotion ST mixer) can also be used depending on your needs.
IOX-XL has 8 analog preamps and line outs, two headphone outs, and an AES in/out. It also includes a built-in SoundGrid DSP server and a network switch, and is designed to be a central hub with networking and processing capabilities.
MultiRack and SuperRack are host applications designed to serve as a multi-channel plugin rack for live sound (FOH/monitoring/broadcast). MultiRack and SuperRack provides control over plugins and snapshots/scenes for live sound systems.
Yes. All DiGiGrid interfaces and ASIO/Core Audio drivers connected to the same SoundGrid network can send and receive Word Clock. Visit the SoundGrid Studio Application page at waves.com to learn more.
DiGiGrid DLS and DLI (the latter with an external SoundGrid DSP server) bridge Pro Tools HD/HDX systems with the SoundGrid low-latency processing platform, enabling you to run hundreds of SoundGrid-compatible Waves and third-party plugins in extremely low latency.
With native systems you can use any DiGiGrid interface (some with an external SoundGrid server). This will enable you to use StudioRack SoundGrid in order to process SoundGrid-compatible Waves and third-party plugins on the SoundGrid DSP server and monitor your tracks with all plugins on in super-low latency.
You can use your old PC or Mac computers with DiGiGrid as long as they meet the minimum requirements. Please see the System Requirements chart in the Waves SoundGrid Studio Application page, under the Support tab.
If you want to use the eMotion ST mixer and StudioRack, we suggest you become familiar with their system requirements and supported hosts as well: eMotion ST (under the Support tab); StudioRack (Tech Specs tab > Supported Hosts tab).
The default processing latency is the same for all DiGiGrid I/Os. The lowest latency to server and back (DSP processing on all systems) is 0.8 ms. If plugins introduce latency, this also needs to be taken into account. For the latencies of individual Waves plugins, consult this plugin latencies chart.
For Native users of DiGiGrid IOS in low-latency monitoring mode, internal processing latency is 0.8 ms + the latency introduced by A/D and D/A convertors. No matter which native buffer parameters are set on your DAW, this is the round trip when you use the StudioRack and eMotion ST low-latency path:
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Yes. No matter whether your session was created with or without SoundGrid processing, instances of StudioRack will load automatically, letting you use the same plugins and settings saved in your session.
When you import a session created on a SoundGrid system to a non-SoundGrid environment, StudioRack will switch seamlessly and automatically from SoundGrid processing to local CPU processing without losing your workflow, and will let you use the same plugin chain presets.
Sessions containing StudioRack components designed especially for Pro Tools HD/HDX and HD Native will load automatically and comply with whichever Pro Tools system is in use, bridging it with the SoundGrid DSP server (if present).
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Staphylococcus aureus is a highly successful opportunistic pathogen: it is a common component of the microbiota of the upper respiratory tract and skin (Foster, 2004) but may also cause a variety of nosocomial and community-acquired infections, ranging from minor skin conditions to life-threatening diseases such as endocarditis, septicemia and toxic shock syndrome (Plata et al., 2009; Thwaites et al., 2011). S. aureus also has the capacity to accumulate antibiotic resistance genes. Infections due to multi-drug-resistant forms such as methicillin-resistant S. aureus (MRSA) can occur in epidemic waves that are initiated by one or a few successful clones and can spread rapidly among hospitalized patients and healthy individuals in the community alike (Chambers and DeLeo, 2009). MRSA isolates are invariably resistant to all β-lactam agents due to the acquisition of mecA or its homolog mecC. These genes encode the low-affinity penicillin binding protein (PBP) 2a, a transpeptidase that forms a functional complex with PBP2 to enable peptidoglycan synthesis after β-lactam acylation of native, membrane-localized PBPs (Fuda et al., 2005; Paterson et al., 2014). MRSA infections are associated with extended hospital stay, high treatment costs, prolonged illness and adverse mortality rates (Datta and Huang, 2008; Anderson et al., 2009) and new treatments and prophylactic measures are urgently needed. Novel treatment options that reduce the rate of emergence of drug resistance would be particularly welcome.
The naturally occurring, abundant polyphenol (-)-epicatechin gallate (ECg) has the capacity to abrogate β-lactam resistance in MRSA, reduce the secretion of virulence effectors such as toxins and tissue-degrading enzymes, and prevent the formation of biofilms (Taylor et al., 2005; Taylor, 2013), making it potentially useful for the control of difficult-to-treat staphylococcal infections. In common with catechins and other catechin gallates, ECg shows a strong tendency to partition into lipid bilayers, including model lipid bilayers comprising single phospholipid species and more complex biological membranes such as the staphylococcal cytoplasmic membrane (CM) (Caturla et al., 2003; Bernal et al., 2010). ECg penetrates deep into the hydrophobic core of the lipid palisade of the staphylococcal bilayer to induce a comprehensive reconfiguration of membrane architecture (Palacios et al., 2014; Rosado et al., 2015), providing a suboptimal environment for the cell wall biosynthetic and cell division machineries. Thus, intercalation of ECg into the staphylococcal CM leads to increased cell wall thickness (Stapleton et al., 2007) and increases in the net negative charge at the bacterial surface due to reductions in D-alanylation of wall teichoic acid (Bernal et al., 2009) and lysylation of phosphatidylglycerol head groups (Bernal et al., 2010; Rosado et al., 2015). Most importantly, ECg intercalation delocalizes PBP2 from the septal site of cell division (Bernal et al., 2010) and disrupts the functional integrity of the cell division assemblage, the divisome (Paulin et al., 2014). These latter effects account for the reversible loss of β-lactam resistance induced by ECg.
The oral bioavailability of naturally occurring catechin gallates in humans and other animals is low (Yashin et al., 2012), they are poorly absorbed from the intestinal tract and are rapidly metabolized to inactive products due to the presence of ester bonds susceptible to enzymatic hydrolysis (Kohri et al., 2001). Further, they appear in the blood circulation mainly in conjugate form after glucuronidation, sulfation, or methylation (Yang et al., 2008). They also display chemical instability (Zhu et al., 1997). Degradation of ECg in biological milieu can be prevented by replacement of a hydrolytically susceptible ester linkage with a stable amide whilst maintaining the natural stereochemistry (Anderson et al., 2005a) and membrane penetration can be enhanced by removal of hydroxyl functions on one of the two ECg pharmacophores (Anderson et al., 2005b, 2011). However, even after optimization of the routes to catechin stereochemistry (Anderson et al., 2014), chemical synthesis of these catechin analogs is sufficiently complex and low-yielding for the generation of adequate quantities of material to enable profiling in small animal models of infection to be unrealistic. We have therefore adapted a model of staphylococcal infection in the zebrafish embryo (Prajsnar et al., 2008) to gain insights into the capacity of ECg to alter the in vivo course of infection with MRSA.
Zebrafish are small tropical freshwater fish native to India, Pakistan, and Bhutan and have provided a powerful model for the study of developmental biology and disease (Goldsmith and Jobin, 2012). External fertilization, ex utero development and the transparency of zebrafish embryos enables the details of embryological processes and development to be investigated using a light microscope, in contrast to the mouse, in which this stage occurs in utero (Stuart et al., 1990). The transparency of zebrafish embryos also allows for fluorescent dyes to be observed in live embryos by microscopy (Herbomel et al., 1999). Embryos possess functional innate immunity and have facilitated the dissection of non-specific host-pathogen interactions during staphylococcal infection (Prajsnar et al., 2008). Here we show that pre-treatment with ECg reduces the lethality of MRSA for zebrafish embryos in both the presence and absence of the β-lactam oxacillin.
Wildtype AB/TULF zebrafish were maintained at the University College London zebrafish facility ( -group) in a multi-rack recirculating system from Aquatic Habitat (Apopka, FL, USA) at an air temperature of 24C, water temperature of 28.5C and pH of 7.6. Adult zebrafish were maintained in 10 L tanks, containing approximately 9 L of filtered, recirculated tap water, with a maximum density of 30 fish. Fish were fed three times daily with a mixture of brine shrimp, krill, and hikari high protein pellets and were daily monitored for signs of disease. Zebrafish were maintained on a 14 h light and 10 h dark photoperiod and embryos collected within 1 h of the onset of the light cycle. Embryos were incubated at 28.5C in E3 medium according to Nsslein-Volhard and Dahm (2002).
b37509886e